Log In
BCIQ
Print this Print this
 

lorcaserin extended release (Belviq XR)

  Manage Alerts
Collapse Summary General Information
Company Arena Pharmaceuticals Inc.
DescriptionOnce-daily extended-release formulation of lorcaserin, a serotonin (5-HT2C) receptor agonist
Molecular Target Serotonin (5-HT2C) receptor
Mechanism of ActionSerotonin (5-HT2C) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationObesity
Indication DetailsChronic weight management
Regulatory Designation
PartnerEisai Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today